Serum albumin, genetic susceptibility, and risk of venous thromboembolism

被引:1
|
作者
Sun, Yuyang [1 ]
Deng, Jun [1 ]
Ding, Yajie [1 ]
Luo, Shanshan
Li, Si
Guan, Yunlong [2 ]
Cao, Xi [2 ]
Hao, Xingjie [2 ]
Hu, Yu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, 1277,Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China
关键词
NEPHROTIC SYNDROME; THROMBOSIS; INFLAMMATION; ASSOCIATION; POPULATION; PREDICTORS; MORTALITY; EVENTS;
D O I
10.1016/j.rpth.2024.102509
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous research on the association between serum albumin (ALB) and venous thromboembolism (VTE) has produced inconclusive results. The polygenic risk score is constructed from a set of independent risk variants associated with a disorder, enabling the identification of a larger fraction of the population at comparable or greater disease risk. It is still unknown whether ALB and genetic factors jointly contribute to the incidence of VTE. Objectives: The present study aimed to explore ALB, genetic susceptibility, and the risk of VTE. Methods: The present investigation was an analysis of prospectively collected data from UK Biobank, a population-based, longitudinal cohort. Cox proportional models were used to calculate hazard ratios and 95% CIs for VTE. The Kaplan-Meier curve was utilized to visualize the cumulative risk of VTE according to different serum ALB levels, and the restricted cubic spline model was leveraged to explore the exposure-response relationship among ALB levels and VTE risk. Results: During median follow-up of 13.5 years, 11,502 cases with VTE were diagnosed among 417,113 participants in the UK Biobank. The lower ALB levels were associated with a higher risk for VTE. Individuals with both a high genetic risk and lowest ALB level had the highest risk of VTE (hazard ratio, 3.89; 95% CI, 3.41-4.43), compared with those with low genetic risk and highest ALB level. The positive joint effects of low ALB and polygenic risk score increased the risk of VTE in individuals with high genetic risk. This study excluded non-European patients and primarily focused on the European population, which may limit the generalizability of the findings. Conclusion: Low serum ALB levels were linked to an increased risk of VTE, which was in accordance with a linear dose-response relationship. There was a positive additive effect of ALB and genetic susceptibility on the risk of VTE. ALB could serve as a biomarker for predicting the risk of VTE.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Serum albumin and risk of venous thromboembolism
    Folsom, Aaron R.
    Lutsey, Pamela L.
    Heckbert, Susan R.
    Cushman, Mary
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) : 100 - 104
  • [2] Genetic susceptibility, smoking, obesity and risk of venous thromboembolism
    Severinsen, Marianne T.
    Overvad, Kim
    Johnsen, Soren P.
    Dethlefsen, Claus
    Madsen, Poul H.
    Tjonneland, Anne
    Kristensen, Soren R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (02) : 273 - 279
  • [3] Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients
    Brand, Judith S.
    Hedayati, Elham
    Humphreys, Keith
    Ludvigsson, Jonas F.
    Johansson, Anna L. V.
    Bergh, Jonas
    Hall, Per
    Czene, Kamila
    CLINICAL CANCER RESEARCH, 2016, 22 (21) : 5249 - 5255
  • [4] Panel of genetic risk markers for prediction of susceptibility towards venous thromboembolism (VTE)
    Srivastava, Swati
    Kumari, Babita
    Garg, Iti
    Prince
    Joshi, Rajneesh Kumar
    Kumar, Rajiv
    Kumar, Dharmendra
    Varshney, Rajeev
    THROMBOSIS RESEARCH, 2024, 241
  • [5] Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients
    Koenigsbruegge, Oliver
    Posch, Florian
    Riedl, Julia
    Reitter, Eva-Maria
    Zielinski, Christoph
    Pabinger, Ingrid
    Ay, Cihan
    ONCOLOGIST, 2016, 21 (02): : 252 - 257
  • [6] Genetic risk factors for venous thromboembolism
    Zoller, Bengt
    Svensson, Peter J.
    Dahlback, Bjorn
    Lind-Hallden, Christina
    Hallden, Christer
    Elf, Johan
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 971 - 981
  • [7] Genetic Risk Factors in Venous Thromboembolism
    Hotoleanu, Cristina
    THROMBOSIS AND EMBOLISM: FROM RESEARCH TO CLINICAL PRACTICE, VOL 1, 2017, 906 : 253 - 272
  • [8] Albumin, oral contraceptives, and venous thromboembolism risk in astronauts
    Zwart, Sara R.
    Aunon-Chancellor, Serena M.
    Heer, Martina
    Melin, M. Mark
    Smith, Scott M.
    JOURNAL OF APPLIED PHYSIOLOGY, 2022, 132 (05) : 1232 - 1239
  • [9] GENETIC SUSCEPTIBILITY AS AN EFFECTMODIFIER FOR THE ASSOCIATION BETWEEN CHRONIC KIDNEY DISEASE AND RISK OF VENOUS THROMBOEMBOLISM
    Zhang, Jingwen
    Shan, Ying
    Liu, Beini
    Dai, Liang
    Song, Congying
    Carrero, Juan Jesus
    Xiong, Zuying
    Huang, Xiaoyan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I519 - I520
  • [10] Genetic influence on risk of venous thromboembolism in women
    Bruzelius, M.
    Sabater-Lleal, M.
    Strawbridge, R. J.
    Bergendal, A.
    Silveira, A.
    Sundstrom, A.
    Kieler, H.
    Odeberg, J.
    Hamsten, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 151 - 151